- Report
- April 2023
- 120 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- August 2020
- 114 Pages
Global
From €4152EUR$4,250USD£3,467GBP
- Report
- November 2023
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Report
- November 2023
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Report
- April 2023
- 200 Pages
United States
From €2565EUR$2,625USD£2,141GBP
€3664EUR$3,750USD£3,059GBP
- Report
- April 2023
- 450 Pages
Global
From €2223EUR$2,275USD£1,856GBP
€3175EUR$3,250USD£2,651GBP
- Report
- April 2023
- 394 Pages
Global
From €5130EUR$5,250USD£4,282GBP
€7328EUR$7,500USD£6,118GBP
- Report
- April 2023
- 197 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €1881EUR$1,925USD£1,570GBP
€2687EUR$2,750USD£2,243GBP
- Report
- August 2022
- 80 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- August 2022
- 167 Pages
Global
From €5130EUR$5,250USD£4,282GBP
€7328EUR$7,500USD£6,118GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 200 Pages
Global
From €5130EUR$5,250USD£4,282GBP
€7328EUR$7,500USD£6,118GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 120 Pages
Global
From €5130EUR$5,250USD£4,282GBP
€7328EUR$7,500USD£6,118GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease.
Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer.
Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more